Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL 10 in ALI/ARDS
NCT00742482Phase 3Terminated
- Sponsor
- LEO Pharma
- Start
- Jan 2003
- Primary completion
- Jan 2005
- Countries
- 12
01
Overview
A Phase 3 trial of HL 10 in acute lung injury (ALI), acute respiratory distress syndrome (ARDS), sponsored by LEO Pharma. Started Jan 2003; status: terminated.
02
Drugs
HL 10
03
Conditions
acute lung injury (ALI)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT00742482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742482.